chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Blood blister, Erythema, Nausea, Pruritus
Clinical narrative: tiny Blood Blisters from her ankle to below her knee on the outside of both legs; Swelling; Itching; Sick to her stomach; red strip about 2 inches wide on both sides of her legs; Nauseated; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD BLISTER (tiny Blood Blisters from her ankle to below her knee on the outside of both legs), SWELLING (Swelling), PRURITUS (Itching), ABDOMINAL DISCOMFORT (Sick to her stomach) and ERYTHEMA (red strip about 2 inches wide on both sides of her legs) in a 77-year-old female patient who received mRNA-1273 (COVID 19 Vaccine Moderna) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arrhythmia (Irregular heart beat), Gastroesophageal reflux disease, Fibromyalgia, Arthritis, Back pain, Neck pain, Hypoxemia (Oxygen level drops at night.) and Neuropathy (Issues with nerves). Concurrent medical conditions included Chronic idiopathic urticaria and Blood pressure high. Concomitant products included OMALIZUMAB (XOLAIR), HYDROXYZINE, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), BENAZEPRIL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE (PROPANOLOL HYDROCHLORIDE), DIGOXIN, PANTOPRAZOLE SODIUM, CODEINE PHOSPHATE, PARACETAMOL (ACETAMINOPHEN AND CODEINE), GABAPENTIN, SERTRALINE and OXYGEN for an unknown indication.   On 05-Apr-2021, the patient received second dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced BLOOD BLISTER (tiny Blood Blisters from her ankle to below her knee on the outside of both legs), SWELLING (Swelling), PRURITUS (Itching), ABDOMINAL DISCOMFORT (Sick to her stomach), ERYTHEMA (red strip about 2 inches wide on both sides of her legs) and NAUSEA (Nauseated). On 27-May-2021, SWELLING (Swelling), PRURITUS (Itching) and NAUSEA (Nauseated) had resolved. At the time of the report, BLOOD BLISTER (tiny Blood Blisters from her ankle to below her knee on the outside of both legs) and ERYTHEMA (red strip about 2 inches wide on both sides of her legs) had resolved and ABDOMINAL DISCOMFORT (Sick to her stomach) outcome was unknown.            Patient took steroids as treatment.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: tiny Blood Blisters from her ankle to below her knee on the outside of both legs; Swelling; Itching; Sick to her stomach; red strip about 2 inches wide on both sides of her legs; Nauseated; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD BLISTER (tiny Blood Blisters from her ankle to below her knee on the outside of both legs), SWELLING (Swelling), PRURITUS (Itching), ABDOMINAL DISCOMFORT (Sick to her stomach) and ERYTHEMA (red strip about 2 inches wide on both sides of her legs) in a 77-year-old female patient who received mRNA-1273 (COVID 19 Vaccine Moderna) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arrhythmia (Irregular heart beat), Gastroesophageal reflux disease, Fibromyalgia, Arthritis, Back pain, Neck pain, Hypoxemia (Oxygen level drops at night.) and Neuropathy (Issues with nerves). Concurrent medical conditions included Chronic idiopathic urticaria and Blood pressure high. Concomitant products included OMALIZUMAB (XOLAIR), HYDROXYZINE, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), BENAZEPRIL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE (PROPANOLOL HYDROCHLORIDE), DIGOXIN, PANTOPRAZOLE SODIUM, CODEINE PHOSPHATE, PARACETAMOL (ACETAMINOPHEN AND CODEINE), GABAPENTIN, SERTRALINE and OXYGEN for an unknown indication.   On 05-Apr-2021, the patient received second dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced BLOOD BLISTER (tiny Blood Blisters from her ankle to below her knee on the outside of both legs), SWELLING (Swelling), PRURITUS (Itching), ABDOMINAL DISCOMFORT (Sick to her stomach), ERYTHEMA (red strip about 2 inches wide on both sides of her legs) and NAUSEA (Nauseated). On 27-May-2021, SWELLING (Swelling), PRURITUS (Itching) and NAUSEA (Nauseated) had resolved. At the time of the report, BLOOD BLISTER (tiny Blood Blisters from her ankle to below her knee on the outside of both legs) and ERYTHEMA (red strip about 2 inches wide on both sides of her legs) had resolved and ABDOMINAL DISCOMFORT (Sick to her stomach) outcome was unknown.            Patient took steroids as treatment.
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Dyspnoea, Pain in extremity, Palpitations
Clinical narrative: heart palpitations; chest pain; trouble breathing; a sore arm; chills; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart palpitations), CHEST PAIN (chest pain), DYSPNOEA (trouble breathing), PAIN IN EXTREMITY (a sore arm) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jul-2021, the patient experienced PALPITATIONS (heart palpitations), CHEST PAIN (chest pain), DYSPNOEA (trouble breathing), PAIN IN EXTREMITY (a sore arm) and CHILLS (chills). At the time of the report, PALPITATIONS (heart palpitations), CHEST PAIN (chest pain), DYSPNOEA (trouble breathing), PAIN IN EXTREMITY (a sore arm) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was reported. No treatment drug details was reported.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Feeling abnormal, Flatulence, Inflammation
Clinical narrative: shortness of breath; irritable bowel; tingling everywhere; Gas; floating; inflammation; chest pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), IRRITABLE BOWEL SYNDROME (irritable bowel), PARAESTHESIA (tingling everywhere), FLATULENCE (Gas) and FEELING ABNORMAL (floating) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath), IRRITABLE BOWEL SYNDROME (irritable bowel), PARAESTHESIA (tingling everywhere), FLATULENCE (Gas), FEELING ABNORMAL (floating), INFLAMMATION (inflammation) and CHEST PAIN (chest pain). At the time of the report, DYSPNOEA (shortness of breath), IRRITABLE BOWEL SYNDROME (irritable bowel), PARAESTHESIA (tingling everywhere), FLATULENCE (Gas), FEELING ABNORMAL (floating), INFLAMMATION (inflammation) and CHEST PAIN (chest pain) outcome was unknown.            Concomitant medication use was unknown Treatment information was unknown   This case was linked to MOD-2021-017731 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Irritable bowel syndrome, Paraesthesia
Clinical narrative: shortness of breath; irritable bowel; tingling everywhere; Gas; floating; inflammation; chest pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), IRRITABLE BOWEL SYNDROME (irritable bowel), PARAESTHESIA (tingling everywhere), FLATULENCE (Gas) and FEELING ABNORMAL (floating) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath), IRRITABLE BOWEL SYNDROME (irritable bowel), PARAESTHESIA (tingling everywhere), FLATULENCE (Gas), FEELING ABNORMAL (floating), INFLAMMATION (inflammation) and CHEST PAIN (chest pain). At the time of the report, DYSPNOEA (shortness of breath), IRRITABLE BOWEL SYNDROME (irritable bowel), PARAESTHESIA (tingling everywhere), FLATULENCE (Gas), FEELING ABNORMAL (floating), INFLAMMATION (inflammation) and CHEST PAIN (chest pain) outcome was unknown.            Concomitant medication use was unknown Treatment information was unknown   This case was linked to MOD-2021-017731 (Patient Link).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: rash enlarged. It reaches down my waist and up to where my bra goes; itchy; rash in my back, at my waist; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (rash enlarged. It reaches down my waist and up to where my bra goes), PRURITUS (itchy) and RASH (rash in my back, at my waist) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     The patient's past medical history included Glaucoma. Concurrent medical conditions included Cancer and Heart Condition. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), AMLODIPINE, LOSARTAN, ATORVASTATIN, LEVOTHYROXINE and METOPROLOL for an unknown indication.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (rash enlarged. It reaches down my waist and up to where my bra goes), PRURITUS (itchy) and RASH (rash in my back, at my waist). The patient was treated with CORTISONE at an unspecified dose and frequency; CALAMINE at an unspecified dose and frequency; PREDNISONE at a dose of 7 20 mg tablets. and TRIAMCINOLONE ACETONIDE at a dose of 0.1 %. At the time of the report, URTICARIA (rash enlarged. It reaches down my waist and up to where my bra goes), PRURITUS (itchy) and RASH (rash in my back, at my waist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       two eye drops for glaucoma- Unknown medicinal product.   This case was linked to MOD-2021-261762 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Non Significant information.
Sex: U
Vaccine: COVID19
Symptoms: Heart rate increased, Nervousness
Clinical narrative: feeling shaky; fast heart rate; This spontaneous case was reported by a patient and describes the occurrence of NERVOUSNESS (feeling shaky) and HEART RATE INCREASED (fast heart rate) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NERVOUSNESS (feeling shaky) and HEART RATE INCREASED (fast heart rate). At the time of the report, NERVOUSNESS (feeling shaky) and HEART RATE INCREASED (fast heart rate) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: a female patient received the 1st dose on 05May2021, but missed the 2nd one; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (a female patient received the 1st dose on 05May2021, but missed the 2nd one) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (a female patient received the 1st dose on 05May2021, but missed the 2nd one). At the time of the report, PRODUCT DOSE OMISSION ISSUE (a female patient received the 1st dose on 05May2021, but missed the 2nd one) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug details were reported. No treatment details were reported.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Photophobia
Clinical narrative: I start to get headaches because of the light sensitivity; exacerbation in photophobia/the photophobia increased a little after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPHOBIA (exacerbation in photophobia/the photophobia increased a little after the 1st dose) and HEADACHE (I start to get headaches because of the light sensitivity) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 006C21A) for COVID-19 vaccination.     The patient's past medical history included Trauma. Concurrent medical conditions included Photophobia. Concomitant products included METFORMIN, GLIMEPIRIDE and ALOGLIPTIN for Diabetes, CELECOXIB and CETIRIZINE for an unknown indication.   On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Jun-2021, the patient experienced PHOTOPHOBIA (exacerbation in photophobia/the photophobia increased a little after the 1st dose). On an unknown date, the patient experienced HEADACHE (I start to get headaches because of the light sensitivity). At the time of the report, PHOTOPHOBIA (exacerbation in photophobia/the photophobia increased a little after the 1st dose) and HEADACHE (I start to get headaches because of the light sensitivity) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant include OTC multivitamins and minerals.  Treatment medicines were not reported.   This case was linked to MOD-2021-261761 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Significant follow-up received, event outcome changed from unknown to not recovered for exacerbation in photophobia and headache.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Nasopharyngitis, Oropharyngeal pain, Sneezing
Clinical narrative: Feels like a slight cold; Sore Throat; Sneezing; Coughing; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Feels like a slight cold), OROPHARYNGEAL PAIN (Sore Throat), SNEEZING (Sneezing) and COUGH (Coughing) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Jul-2021, the patient experienced NASOPHARYNGITIS (Feels like a slight cold), OROPHARYNGEAL PAIN (Sore Throat), SNEEZING (Sneezing) and COUGH (Coughing). On 20-Jul-2021, OROPHARYNGEAL PAIN (Sore Throat) had resolved. At the time of the report, NASOPHARYNGITIS (Feels like a slight cold), SNEEZING (Sneezing) and COUGH (Coughing) had resolved.            No relevant concomitant medications were reported.  Treatment information included cold syrup and antibiotics.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Outcome of the event was updated to recovered/resolved.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Headache, Photophobia
Clinical narrative: Headache; A bigger exacerbation in his photophobia; A bigger exacerbation in his photophobia; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPHOBIA (A bigger exacerbation in his photophobia), CONDITION AGGRAVATED (A bigger exacerbation in his photophobia) and HEADACHE (Headache) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006C21A and 048B21A) for COVID-19 vaccination.     The patient's past medical history included Trauma. Concurrent medical conditions included Photophobia. Concomitant products included METFORMIN, GLIMEPIRIDE, ALOGLIPTIN, CELECOXIB, CETIRIZINE, MULTI VIT and MINERALS for an unknown indication.   On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jun-2021, the patient experienced PHOTOPHOBIA (A bigger exacerbation in his photophobia) and CONDITION AGGRAVATED (A bigger exacerbation in his photophobia). On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, PHOTOPHOBIA (A bigger exacerbation in his photophobia), CONDITION AGGRAVATED (A bigger exacerbation in his photophobia) and HEADACHE (Headache) had not resolved.            No treatment medication information was provided.   This case was linked to MOD-2021-261758 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Significant follow-up received: Outcome changed from unknown to not recovered
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: It is itching; rash got worse after second dose rash enlarged. It reaches down my waist and up to where my bra goes; . This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash got worse after second dose rash enlarged. It reaches down my waist and up to where my bra goes) and PRURITUS (It is itching) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051C21A. and 003C21A) for COVID-19 vaccination.     The patient's past medical history included Cancer. Concurrent medical conditions included Heart disorder and Glaucoma. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), AMLODIPINE, LOSARTAN, ATORVASTATIN, LEVOTHYROXINE and METOPROLOL for an unknown indication.   On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (rash got worse after second dose rash enlarged. It reaches down my waist and up to where my bra goes) and PRURITUS (It is itching). The patient was treated with HYDROCORTISONE (CORTISONE [HYDROCORTISONE]) for Adverse reaction, at an unspecified dose and frequency; CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) for Adverse reaction, at an unspecified dose and frequency; PREDNISONE for Adverse reaction, at an unspecified dose and frequency and TRIAMCINOLONE for Adverse reaction, at an unspecified dose and frequency. At the time of the report, RASH (rash got worse after second dose rash enlarged. It reaches down my waist and up to where my bra goes) and PRURITUS (It is itching) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-261754.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow received  on 20-JUL-2021 contact details for HCP and vaccination site
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Patient very sick after receiving the Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Patient very sick after receiving the Moderna COVID-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Patient very sick after receiving the Moderna COVID-19 vaccine). At the time of the report, VACCINATION COMPLICATION (Patient very sick after receiving the Moderna COVID-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Still feel fatigue eight days after vaccine/Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Still feel fatigue eight days after vaccine/Fatigue) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Still feel fatigue eight days after vaccine/Fatigue). At the time of the report, FATIGUE (Still feel fatigue eight days after vaccine/Fatigue) had not resolved.            No concomitant product reported by reporter. No treatment medication reported by reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow up received. Reporter contact information updated. Patient Date of Birth added. Dose information added.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: developed rash at the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE RASH (developed rash at the injection site) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (developed rash at the injection site). At the time of the report, VACCINATION SITE RASH (developed rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    No relevant concomitant medications were reported. No treatment information was provided.
Age: 74.0
Sex: U
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Neck pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of neck pain and musculoskeletal stiffness (neck felt like a brick) in a 74-year-old patient, of an unknown gender,  who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced neck pain and musculoskeletal stiffness (neck felt like a brick). At the time of the report, neck pain and musculoskeletal stiffness (neck felt like a brick) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: slight headache after second dose; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (slight headache after second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (slight headache after second dose). At the time of the report, HEADACHE (slight headache after second dose) outcome was unknown.            No concomitant medications were reported. No treatment details were reported.   This case was linked to MOD-2021-261577, MOD-2021-261786 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Electrocardiogram abnormal, Pain in jaw
Clinical narrative: EKG rythm was off; hurtful feeling in her jaw; hurtful feeling in the ear; This spontaneous case was reported by a consumer and describes the occurrence of ELECTROCARDIOGRAM ABNORMAL (EKG rythm was off), PAIN IN JAW (hurtful feeling in her jaw) and EAR PAIN (hurtful feeling in the ear) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ELECTROCARDIOGRAM ABNORMAL (EKG rythm was off), PAIN IN JAW (hurtful feeling in her jaw) and EAR PAIN (hurtful feeling in the ear). At the time of the report, ELECTROCARDIOGRAM ABNORMAL (EKG rythm was off), PAIN IN JAW (hurtful feeling in her jaw) and EAR PAIN (hurtful feeling in the ear) outcome was unknown.            Concomitant product was not provided. Treatment medication was not reported.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Hypersomnia, Neck pain, Pain, Pain in extremity
Clinical narrative: severe shooting pain to his neck; severe shooting pain down his left arm/severe shooting pain to his hand/severe shooting pain in his toes; Slept a lot those days; Shooting pain; severe shooting pain in his left shoulder/severe shooting pain in his knee joints; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (severe shooting pain to his neck), PAIN IN EXTREMITY (severe shooting pain down his left arm/severe shooting pain to his hand/severe shooting pain in his toes), HYPERSOMNIA (Slept a lot those days), PAIN (Shooting pain) and ARTHRALGIA (severe shooting pain in his left shoulder/severe shooting pain in his knee joints) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NECK PAIN (severe shooting pain to his neck), PAIN IN EXTREMITY (severe shooting pain down his left arm/severe shooting pain to his hand/severe shooting pain in his toes), HYPERSOMNIA (Slept a lot those days), PAIN (Shooting pain) and ARTHRALGIA (severe shooting pain in his left shoulder/severe shooting pain in his knee joints). At the time of the report, NECK PAIN (severe shooting pain to his neck), PAIN IN EXTREMITY (severe shooting pain down his left arm/severe shooting pain to his hand/severe shooting pain in his toes), HYPERSOMNIA (Slept a lot those days), PAIN (Shooting pain) and ARTHRALGIA (severe shooting pain in his left shoulder/severe shooting pain in his knee joints) had resolved.            Concomitant medication use was unknown Treatment information was unknown   This case was linked to MOD-2021-261775 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: swollen feet; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen feet) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jul-2021, the patient experienced PERIPHERAL SWELLING (swollen feet). At the time of the report, PERIPHERAL SWELLING (swollen feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Ill-defined disorder
Clinical narrative: already had the virus with minimal symptoms; already had the virus with minimal symptoms; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (already had the virus with minimal symptoms) and ILL-DEFINED DISORDER (already had the virus with minimal symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (already had the virus with minimal symptoms) and ILL-DEFINED DISORDER (already had the virus with minimal symptoms). At the time of the report, COVID-19 (already had the virus with minimal symptoms) and ILL-DEFINED DISORDER (already had the virus with minimal symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information were provided. No treatment information were provided.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Echocardiogram, Hypoaesthesia, Pain in extremity
Clinical narrative: Numbness on left side(whole left side/in arm and extended into lips; Tingling on left side(whole left side/in arm and extended into lips; Dull pain in chest; Hand ache; wrist ache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness on left side(whole left side/in arm and extended into lips), PARAESTHESIA (Tingling on left side(whole left side/in arm and extended into lips), CHEST PAIN (Dull pain in chest), PAIN IN EXTREMITY (Hand ache) and ARTHRALGIA (wrist ache) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 031LZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness on left side(whole left side/in arm and extended into lips), PARAESTHESIA (Tingling on left side(whole left side/in arm and extended into lips), CHEST PAIN (Dull pain in chest), PAIN IN EXTREMITY (Hand ache) and ARTHRALGIA (wrist ache). At the time of the report, HYPOAESTHESIA (Numbness on left side(whole left side/in arm and extended into lips), PARAESTHESIA (Tingling on left side(whole left side/in arm and extended into lips), CHEST PAIN (Dull pain in chest), PAIN IN EXTREMITY (Hand ache) and ARTHRALGIA (wrist ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Echocardiogram: normal (normal) Normal.         Concomitant medication was not provided.  Treatment information was not provided.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Numbness on left side(whole left side/in arm and extended into lips; Tingling on left side(whole left side/in arm and extended into lips; Dull pain in chest; Hand ache; wrist ache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness on left side(whole left side/in arm and extended into lips), PARAESTHESIA (Tingling on left side(whole left side/in arm and extended into lips), CHEST PAIN (Dull pain in chest), PAIN IN EXTREMITY (Hand ache) and ARTHRALGIA (wrist ache) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 031LZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness on left side(whole left side/in arm and extended into lips), PARAESTHESIA (Tingling on left side(whole left side/in arm and extended into lips), CHEST PAIN (Dull pain in chest), PAIN IN EXTREMITY (Hand ache) and ARTHRALGIA (wrist ache). At the time of the report, HYPOAESTHESIA (Numbness on left side(whole left side/in arm and extended into lips), PARAESTHESIA (Tingling on left side(whole left side/in arm and extended into lips), CHEST PAIN (Dull pain in chest), PAIN IN EXTREMITY (Hand ache) and ARTHRALGIA (wrist ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Echocardiogram: normal (normal) Normal.         Concomitant medication was not provided.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Fever; Was Tired; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and FATIGUE (Was Tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and FATIGUE (Was Tired). At the time of the report, PYREXIA (Fever) and FATIGUE (Was Tired) outcome was unknown.            No concomitant medication were reported. No treatment information was reported.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 14 year old Vaccinated with Moderna COVID-19 Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (14 year old Vaccinated with Moderna COVID-19 Vaccine) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (14 year old Vaccinated with Moderna COVID-19 Vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (14 year old Vaccinated with Moderna COVID-19 Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow up received contains no new information (NNI)
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: has not received his 2nd dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jul-2021 and was forwarded to Moderna on 20-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (has not received his 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (has not received his 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (has not received his 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   No treatment information was provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: I have fever 10 days after the 2nd vaccine; Second vaccine made me have deep body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (I have fever 10 days after the 2nd vaccine) and MYALGIA (Second vaccine made me have deep body aches) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037a21b) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Tumor (hemotherapy which has protocol of chop-bleo and methrexate for tumor in throat) in 1986, Chemotherapy (took chemotherapy which has protocol of chop-bleo and methrexate for tumor in throat) in 1986 and Anesthesia (patient had anesthesia with which she took 18hrs to wakeup and she was delicate person.). Concurrent medical conditions included Drug allergy (allergic to nausea medicines) and Penicillin allergy.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (I have fever 10 days after the 2nd vaccine) and MYALGIA (Second vaccine made me have deep body aches). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PYREXIA (I have fever 10 days after the 2nd vaccine) and MYALGIA (Second vaccine made me have deep body aches) had resolved.            Concomitant products included Thyroid pills and Antidepressant pills. patient had extreme immune response. Patient have extremely delicate constitution.   This case was linked to MOD-2021-104509 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Depression, Fall, Product dose omission issue, Wrist fracture
Clinical narrative: Did not received her second shot that was scheduled back in April2021; Fell; Broke her wrists; She has been depressed; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Did not received her second shot that was scheduled back in April2021), FALL (Fell), WRIST FRACTURE (Broke her wrists) and DEPRESSION (She has been depressed) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not received her second shot that was scheduled back in April2021), FALL (Fell), WRIST FRACTURE (Broke her wrists) and DEPRESSION (She has been depressed). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Did not received her second shot that was scheduled back in April2021) had resolved and FALL (Fell), WRIST FRACTURE (Broke her wrists) and DEPRESSION (She has been depressed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was provided.  The patient does not have information regarding to her first shot.
Sex: U
Vaccine: COVID19
Symptoms: Bronchitis, Inappropriate schedule of product administration, Product dose omission issue
Clinical narrative: Got Bronchitis; still haven't gotten my second dose; What if I get the second dose after 3 months; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHITIS (Got Bronchitis), PRODUCT DOSE OMISSION ISSUE (still haven't gotten my second dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (What if I get the second dose after 3 months) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BRONCHITIS (Got Bronchitis), PRODUCT DOSE OMISSION ISSUE (still haven't gotten my second dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (What if I get the second dose after 3 months). At the time of the report, BRONCHITIS (Got Bronchitis), PRODUCT DOSE OMISSION ISSUE (still haven't gotten my second dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (What if I get the second dose after 3 months) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported. No Treatment information was reported. Patient has stated that patient had wait until the event bronchitis got resolved.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Report side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Report side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Report side effects). At the time of the report, VACCINATION COMPLICATION (Report side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Unspecific adverse event.; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (Unspecific adverse event.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Unspecific adverse event.). At the time of the report, VACCINATION COMPLICATION (Unspecific adverse event.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: She had a little sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (She had a little sore arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L201A) for COVID-19 vaccination.     Concomitant products included METFORMIN, AMLODIPINE, MELOXICAM, SIMVASTATIN, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), MECOBALAMIN (VITAMIN B12 [MECOBALAMIN]) and ELDERBERRY [SAMBUCUS NIGRA] for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (She had a little sore arm). At the time of the report, PAIN IN EXTREMITY (She had a little sore arm) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided   This case was linked to MOD-2021-261717 (Patient Link).
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient has not received the second dose of the vaccine and it has been more than 36 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient has not received the second dose of the vaccine and it has been more than 36 days) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient has not received the second dose of the vaccine and it has been more than 36 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient has not received the second dose of the vaccine and it has been more than 36 days) had resolved.            Concomitant drug was not reported.  Treatment medication was not reported.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: I have been experiencing diarrhea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (I have been experiencing diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (I have been experiencing diarrhea). At the time of the report, DIARRHOEA (I have been experiencing diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information  was provided. No treatment medication information was provided.